Department of Interventional Therapy;
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital;
Chinese Academy of Medical Sciences and Peking Union Medical College;
Beijing 100021;
China;
Department of Biostatistics;
School of Public Health;
Fudan University;
Shanghai 200034;
China;
Hepatocellular carcinoma; Systemic therapy; Meta-analysis; Lenvatinib; Firstline; Immune therapy;